Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Shield Therapeutics plc

SHIEFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.14
$0.00(0.00%)
U.S. Market opens in 7h 52m

SHIEF News Today: Stay Updated with the Latest Shield Therapeutics plc News in Real Time

Find SHIEF news now at Meyka AI. Stay informed with the latest Shield Therapeutics plc stocks updates, including price news, market analysis, and expert insights.

Jefferies Maintains Hold on Perrigo Company plc (PRGO) Feb 26, 2026 $18 PT
📅 in about 4 hours

Jefferies Maintains Hold on Perrigo Company plc (PRGO) Feb 26, 2026 $18 PT

Jefferies keeps Hold on Perrigo Company plc with $18 PT; PRGO analyst rating maintained Feb 26, 2026

Read more
Vol 15,112 hits ORPH.IR Open Orphan (EURONEXT) 27 Feb 2026: watch EUR 0.14 support
📅 in about 4 hours

Vol 15,112 hits ORPH.IR Open Orphan (EURONEXT) 27 Feb 2026: watch EUR 0.14 support

Pre-market volume spike in ORPH.IR stock to 15,112, trading at EUR 0.14 on EURONEXT; quick analysis and price outlook

Read more
Jefferies Maintains Buy, PT $45 for Viridian Therapeutics (VRDN) Feb 2026
📅 in about 3 hours

Jefferies Maintains Buy, PT $45 for Viridian Therapeutics (VRDN) Feb 2026

VRDN analyst rating: Jefferies maintains Buy with $45 PT and Evercore keeps Outperform in Feb 2026

Read more
Citigroup upgrades AngloGold Ashanti Plc (AU) to Buy Feb 26, 2026
📅 in about 1 hour

Citigroup upgrades AngloGold Ashanti Plc (AU) to Buy Feb 26, 2026

Citigroup upgrade raises AU analyst rating for AngloGold Ashanti Plc on Feb 26, 2026

Read more
KYMR: Kymera Therapeutics Maintained Outperform by RBC Capital Feb 26 2026
📅 38 minutes ago

KYMR: Kymera Therapeutics Maintained Outperform by RBC Capital Feb 26 2026

RBC Capital maintained KYMR analyst rating at Outperform and raised PT to $108 on Feb 26 2026; implications and Meyka AI grade B+

Read more
Barclays Maintains Overweight on C4 Therapeutics (CCCC) Feb 26, 2026
📅 2 hours ago

Barclays Maintains Overweight on C4 Therapeutics (CCCC) Feb 26, 2026

Barclays and Cowen maintain ratings on C4 Therapeutics. Read Feb 26, 2026 CCCC analyst rating and implications

Read more
H.C. Wainwright Maintains Buy on United Therapeutics (UTHR) Feb 2026
📅 3 hours ago

H.C. Wainwright Maintains Buy on United Therapeutics (UTHR) Feb 2026

H.C. Wainwright maintained Buy on United Therapeutics (UTHR) and raised the PT to $600 in Feb 2026 — UTHR analyst rating update

Read more
Smurfit Kappa SK3.IR EURONEXT closed EUR 41.44 26 Feb 2026: heavy volume view
📅 7 hours ago

Smurfit Kappa SK3.IR EURONEXT closed EUR 41.44 26 Feb 2026: heavy volume view

SK3.IR stock: Smurfit Kappa closed EUR 41.44 on 26 Feb 2026 with heavy volume and a Meyka AI forecast of +37.86%

Read more
FTI.PA TechnipFMC Euronext after-hours €5.91 Feb 2026: most-active, upside seen
📅 7 hours ago

FTI.PA TechnipFMC Euronext after-hours €5.91 Feb 2026: most-active, upside seen

After-hours volume spikes on FTI.PA stock at €5.912; analysis covers valuation, news, Meyka AI forecast and trading setup

Read more

SHIEF News FAQ